Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.

A major international trial has found that pulsed-field catheter ablation offers superior outcomes to antiarrhythmic drugs ...

A major clinical trial has found Boston Scientific’s Farapulse pulsed-field ablation system significantly more effective than medication for patients with persistent atrial fibrillation who had not ...

HEART PROCEDURE SUPERIOR TO DRUGS FOR COMMON ARRHYTHMIA A minimally invasive procedure that “rewires” ‌the heart may be a ...

At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...

Stanford's Dr. Perez shows Apple Watches detect AFib with 86% accuracy, offering accessible cardiac monitoring as 115M ...

In patients with persistent atrial fibrillation, those receiving pulsed field ablation as first-line therapy had less risk ...

Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).

AFNET 6 trial used large language models to extract AF burden from pacemaker data in patients with device-detected atrial fibrillation. This approach enables to evaluate the impact of AF burden on ...

Medtronic plc, , a global leader in healthcare technology, today announced continued momentum for the Afferatm family of technologies for cardiac arrhythmia treatment, including promising data ...

COMPASS presents a “scalable framework” for other centers that want to improve AF care, but additional efforts are needed.